SCHEMBL4111371

SCHEMBL4111371

C=CCOC(=O)C=CCc1cc(F)c(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.47
MAPT P10636 3/20 0.41
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
CYP3A4 P08684 1/20 0.36
TSHR P16473 2/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MMP2 P08253 2/20 0.33
MMP1 P03956 1/20 0.33
MMP9 P14780 1/20 0.33
MMP12 P39900 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ADRB2 P07550 2/20 0.31
HTR1A P08908 2/20 0.31
CHRM5 P08912 2/20 0.31
ADRA2A P08913 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4111368 1.00 APP (0.47) APPMAPTCACNA1BAPBA1CYP3A4
SCHEMBL32677337 0.83 CYP3A4 (0.44) MAPTCYP3A4ALDH1A1TTRLMNA
SCHEMBL12971288 0.80 DPP4 (0.40) APPMAPTPOLBALDH1A1MEN1
SCHEMBL12971290 0.80 DPP4 (0.40) APPMAPTPOLBALDH1A1MEN1
SCHEMBL14127535 0.75 MIF (0.36) CYP3A4TSHRALDH1A1MMP2MMP1
SCHEMBL14127537 0.75 MIF (0.36) CYP3A4TSHRALDH1A1MMP2MMP1
SCHEMBL15853223 0.74 DPP4 (0.34) CYP3A4MMP2MMP1MMP9MMP12
SCHEMBL3801146 0.74 MAPT (0.39) APPMAPTCACNA1BAPBA1CYP3A4
SCHEMBL3801151 0.74 MAPT (0.39) APPMAPTCACNA1BAPBA1CYP3A4
SCHEMBL2640817 0.72 CYP3A4 (0.35) APPMAPTCACNA1BAPBA1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009064476-A1 PREPARATION OF SITAGLIPTIN INTERMEDIATE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-05-22 WO disclosed